Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

73

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

73 results for “non-obese”

Learn how ShareScore rates datasets ↗
geo24/100

RNA-seq Analysis of Differential Gene Expression in Obese Compared with Non-Obese Breast Cancer Patients

GEO Series GSE148892. Homo sapiens. 26 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenSep 2020View details →
geo20/100

Expression data from Adipose Stem Cells (ASC) from morbidly obese and non-obese individuals

GEO Series GSE48964. Homo sapiens. 6 samples. Type: Expression profiling by array.

openGEO-OpenSep 2013View details →
geo20/100

Resveratrol supplementation does not improve metabolic function in non-obese women with normal glucose tolerance

GEO Series GSE41168. Homo sapiens. 140 samples. Type: Expression profiling by array.

openGEO-OpenJan 2013View details →
geo20/100

Individualized analysis of subcutaneous and omental abdominal adipose tissue from non-obese and obese subjects

GEO Series GSE15524. Homo sapiens. 28 samples. Type: Expression profiling by array.

openGEO-OpenApr 2009View details →
zenodo20/100

Data set for serum Lead in non-obese workers

<p>dataset</p>

opencc-by-4.0Oct 2023View details →
ClinicalTrials.gov20/100

Assessment of Obstructive Sleep Apnea Syndrome in Non-Obese Patients

ClinicalTrials.gov study NCT05814796. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
geo16/100

Comparative assessment of the transcriptome of pancreatic islets from Non-Obese Diabetic mice in the absence of immune infiltrate

GEO Series GSE56507. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenFeb 2016View details →
geo16/100

Gene expression in the islets of 10 day old, 4 week old and 12 week old Non-Obese Diabetic (NOD) mice vs. healthy, age-matched NOD.B10 control mice

GEO Series GSE149086. Mus musculus. 18 samples. Type: Expression profiling by array.

openGEO-OpenApr 2020View details →
geo16/100

RNAseq of Islet CD11c+ cells and Islet T cells from 12-20 week non-obese diabetic mice

GEO Series GSE121804. Mus musculus. 13 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenMar 2019View details →
geo16/100

Genome-Wide Gene Expression Profiles in the Pancreatic Lymph Nodes of non-obese diabetic (NOD) mice

GEO Series GSE66658. Mus musculus. 17 samples. Type: Expression profiling by array.

openGEO-OpenMar 2015View details →
geo12/100

PWS gene expression profiling of obese and non-obese patients

GEO Series GSE285348. Homo sapiens. 50 samples. Type: Expression profiling by array.

openGEO-OpenMay 2025View details →
zenodo12/100

Comparing Effects of Ultra Low Dose (Ethinyl Estradiol 20µg or 15µg) with Low Dose (Ethinyl Estradiol 30µg) Hormonal Pills on Lipid Discordance in Non-Obese PCOS Women: A Randomized Control Trial

<p>Ultra-low dose hormonal pills have become the favoured treatment option over low dose pills in PCOS. Existing literature shows marked heterogeneity in metabolic effects of pills with different compositions. This might have been due to improper choice of outcome variable for comparison. Total cholesterol - high density lipoprotein ratio (TC/HDL) discordance with Low Density Lipoprotein cholesterol (LDL-C) was a better marker of future risk of atherosclerotic cardio-vascular disease and stable to variations. Present study was a randomised controlled trial conducted to compare prevalence of TC/HDL and LDL discordance among non-obese PCOS women treated with hormonal pills of different compositions. Role of baseline participant features and pill composition on discordance after treatment was determined. Women were randomised into three arms, two arms receiving ultra-low dose pills (either Ethinyl Estradiol 20&micro;g with drosperinone 3mg or Ethinyl Estradiol 15&micro;g with gestodene 60&micro;g) and one arm receiving low dose pill (Ethinyl Estradiol 30&micro;g with desogestrel 150 &micro;g). Discordance was observed in more than 1/4<sup>th</sup> participants prior to intervention. After one year of treatment less than 1/5<sup>th</sup> of participants were discordant. Ultra-low dose pill users had lower discordance, LDL and TC compared to low dose pill users after one year of treatment. Random Forest a non-linear classifier showed the highest accuracy in predicting discordance. Baseline Parameters having maximal impact on occurrence of discordance were triglyceride (TG), HOMA-IR, BMI and HDL.Ultra-low dose hormonal pills have become the favoured treatment option over low dose pills in PCOS. Existing literature shows marked heterogeneity in metabolic effects of pills with different compositions. This might have been due to improper choice of outcome variable for comparison. Total cholesterol - high density lipoprotein ratio (TC/HDL) discordance with Low Density Lipoprotein cholesterol (LDL-C) was a better marker of future risk of atherosclerotic cardio-vascular disease and stable to variations. Present study was a randomised controlled trial conducted to compare prevalence of TC/HDL and LDL discordance among non-obese PCOS women treated with hormonal pills of different compositions. Role of baseline participant features and pill composition on discordance after treatment was determined. Women were randomised into three arms, two arms receiving ultra-low dose pills (either Ethinyl Estradiol 20&micro;g with drosperinone 3mg or Ethinyl Estradiol 15&micro;g with gestodene 60&micro;g) and one arm receiving low dose pill (Ethinyl Estradiol 30&micro;g with desogestrel 150 &micro;g). Discordance was observed in more than 1/4<sup>th</sup> participants prior to intervention. After one year of treatment less than 1/5<sup>th</sup> of participants were discordant. Ultra-low dose pill users had lower discordance, LDL and TC compared to low dose pill users after one year of treatment. Random Forest a non-linear classifier showed the highest accuracy in predicting discordance. Baseline Parameters having maximal impact on occurrence of discordance were triglyceride (TG), HOMA-IR, BMI and HDL.</p>

restrictedJul 2023View details →
dryad0/100

Data from: Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study

OBJECTIVES: The relationship between normal low-density lipoprotein cholesterol (LDL-c) levels and nonalcoholic fatty liver disease (NAFLD) in non-obese subjects remains unclear. We aimed to investigate the precise prevalence and incidence of NAFLD within the normal LDL-c range in non-obese subjects. Design: Cross-sectional and longitudinal study. Setting: Wenzhou Medical Center of Wenzhou People's Hospital from 2010 to 2014. Participants: 183903 non-obese individuals were enrolled from a cross-sectional population and a total of 16173 initially NAFLD-free non-obese subjects were included who completed a 5-year follow-up examination in the longitudinal population. RESULTS: In our study, NAFLD was defined by ultrasonographic detection of steatosis in the absence of other liver disease. The cross-sectional study showed that at baseline, the prevalence of NAFLD was 13.9% in non-obese subjects with normal LDL-c levels. The prospective study demonstrated that NAFLD-free subjects developed NAFLD during the 5-year follow-up period, with a cumulative incidence of 14.4%. In addition, the OR for NAFLD in the cross-sectional population were 1.11(95%CI 1.04-1.18), 1.37 (95%CI 1.27-1.47), and 1.56 (95%CI 1.43-1.69), respectively, after adjusting for known confounding variables. The HR for NAFLD in the longitudinal population were 1.15 (95%CI 0.98-1.36), 1.32 (95%CI 1.10-1.58) and 1.82 (95%CI 1.47-2.52), compared with Q1. Subjects with higher LDL-c level within the normal range had an increased cumulative incidence rate of NAFLD in non-obese subjects. CONCLUSIONS: NAFLD is prevalent in the non-obese Chinese population. Furthermore, this is the first study to demonstrate that increased normal LDL-c levels are independently associated with an elevated risk of NAFLD in non-obese subjects.

opencc-zeroDec 2015View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record